Fennec Pharmaceuticals Inc. (FENC)
NASDAQ: FENC · Real-Time Price · USD
5.99
+0.15 (2.57%)
Dec 20, 2024, 4:00 PM EST - Market closed
Fennec Pharmaceuticals Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for FENC stock have an average target of 14, with a low estimate of 13 and a high estimate of 15. The average target predicts an increase of 133.72% from the current stock price of 5.99.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for FENC stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $13 | Strong Buy | Reiterates | $13 | +117.03% | Dec 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $15 → $13 | Strong Buy | Maintains | $15 → $13 | +117.03% | Aug 22, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $17 → $15 | Strong Buy | Maintains | $17 → $15 | +150.42% | Aug 14, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $20 → $17 | Strong Buy | Maintains | $20 → $17 | +183.81% | May 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $18 → $15 | Strong Buy | Maintains | $18 → $15 | +150.42% | May 15, 2024 |
Financial Forecast
Revenue This Year
44.02M
from 21.25M
Increased by 107.12%
Revenue Next Year
58.71M
from 44.02M
Increased by 33.37%
EPS This Year
0.04
from -0.60
EPS Next Year
0.10
from 0.04
Increased by 192.14%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 51.3M | 96.9M | 112.9M | |||
| Avg | 44.0M | 58.7M | 83.5M | |||
| Low | 28.7M | 42.9M | 65.2M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 141.6% | 120.1% | 92.3% | |||
| Avg | 107.1% | 33.4% | 42.2% | |||
| Low | 34.8% | -2.5% | 11.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 0.28 | 0.51 | 2.57 | |||
| Avg | 0.04 | 0.10 | 1.58 | |||
| Low | -0.05 | -0.31 | 0.74 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | 1,341.2% | 2,366.6% | |||
| Avg | - | 192.1% | 1,412.6% | |||
| Low | - | - | 604.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.